Reduced CD160 expression contributes to impaired NK cell function and poor clinical outcomes in patients with HCC. Cancer Res. 2018;78:6581.

Science

Works on an Innovative Immunotherapeutic Approach Against

Cancer, Virus Infection and Autoimmune Diseases

Home > Science > Reduced CD160 expression contributes to impaired NK cell function and poor clinical outcomes in patients with HCC. Cancer Res. 2018;78:6581.

Science

Reduced CD160 expression contributes to impaired NK cell function and poor clinical outcomes in patients with HCC. Cancer Res. 2018;78:6581.

2018-09-19

share:

ICP备字：皖ICP备2022011087号-1 （皖）-非经营性-2022-0075 皖公网安备 34019102001077号 ©Copyright by TGI All rights reserved.

网站技术支持：网新科技

Legal Statement Privacy Policy Terms Of Use